The symposium focuses on the balance between over- and under-treatment of colon and rectal cancer. The event spans two days, January 30–31, bringing together international experts to discuss the latest treatment methods in the field.
The program includes panel discussions, case studies, and lectures exploring both surgical and non-surgical approaches. Experts from the Nordic countries and the Netherlands will share insights into current challenges and new technological advancements in colorectal surgery.
This symposium offers a unique opportunity for gastroenterologists, colorectal surgeons, and general surgeons to stay updated on the latest research and engage in discussions about the future of treatment with leading specialists.
Participation
Fee: NOK 3200
It is also possible to attend the symposium via streaming.
Program
08:30–09:00: Registration
09:00–09:10: Welcome, Augestad/Schultz
09:10–09:30: Oral antibiotic bowel preparation in colorectal cancer: Mobile trials
Speaker: Laura Koskenvuo (FI)
09:30–09:50: Stoma construction and (early) closure – how to prevent complications
Speaker: Eva Angenete (SE)
09:50–10:10: Early onset colorectal cancer
Speaker: Anna Martling (SE)
10:10–10:30: Coffee break
10:30–10:50: Endoscopic removal of early colon cancer and polyp scars
Speaker: Nastazja Pilonis (PL)
10:50–11:10: Hybrid wedge resection of early colon cancer
Speaker: Erik van Westreenen (NL)
11:10–11:30: Immunotherapy for colon cancer
Speaker: Åse Dahle-Smith (Ahus)
11:30–11:40: Surgery after immunotherapy – if, when, and how
Speaker: Erik Kjæstad (Ahus)
11:40–12:30: Panel debate: Are surgeons becoming redundant in colon cancer treatment?
12:30–13:30: Lunch
13:30–13:50: Robot-assisted versus laparoscopic approach to colon cancer
Speaker: Pedja Cuk (DK)
13:50–14:10: Robotic colorectal surgery – just a cost driver or a fundamental improvement?
Speaker: Ritch Geitenbeek (NL)
14:10–14:30: Indocyanine Green Fluorescence (ICG) – just hype or a valuable tool?
Speaker: Roel Hompes (NL)
14:30–14:50: Acetylsalicylic acid after colorectal cancer resection – ALASCCA results
Speaker: Anna Martling (SE)
14:50–15:10: Coffee break
15:10–15:30: (Neo-)adjuvant treatment for colon cancer – the line between over- and undertreatment
Speaker: Laurids Poulsen (DK)
15:30–16:30: MDT meeting on colon cancer (3 cases)
16:30: Adjourn
09:00–09:20: Role of MRI staging and restaging in rectal cancer
Speaker: Anne Negård (Ahus)
09:20–09:40: Total neoadjuvant therapy in rectal cancer – controversies and future directions
Speaker: Anne Hansen Ree (Ahus)
09:40–10:00: Intentional "watch and wait" in early rectal cancer (WW1 & 2 trials, Denmark)
Speaker: Laurids Poulsen (DK)
10:00–10:20: Opportunistic "watch and wait" strategies (WOW study, Sweden)
Speaker: Eva Angenete (SE)
10:20–10:40: Coffee break
10:40–11:00: Pitfalls of "watch and wait" – organ preservation at any cost?
Speaker: Johannes K. Schultz (Ahus)
11:00–11:20: Surgical approach to early rectal cancer
Speaker: Roel Hompes (DK)
11:20–11:40: Endoscopic approach to early rectal cancer
Speaker: Nastazja Pilonis (PL)
11:40–12:30: Lunch
12:30–13:15: Panel debate: International differences in (neo-)adjuvant treatment strategies
13:15–14:00: MDT meeting on rectal cancer (2 cases)
